Detalles de la búsqueda
1.
Multicenter Harmonization Study of Pan-Trk Immunohistochemistry for the Detection of NTRK3 Fusions.
Mod Pathol
; 36(8): 100192, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37084942
2.
Radiation therapy for triple-negative breast cancer: emerging role of microRNAs as biomarkers and radiosensitivity modifiers. A systematic review.
Breast Cancer Res Treat
; 193(2): 265-279, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35397079
3.
Circulating proteins as predictive and prognostic biomarkers in breast cancer.
Clin Proteomics
; 19(1): 25, 2022 Jul 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35818030
4.
Breast conservation and axillary management after primary systemic therapy in patients with early-stage breast cancer: the Lucerne toolbox.
Lancet Oncol
; 22(1): e18-e28, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33387500
5.
Infiltrating and peripheral immune cell analysis in advanced gastric cancer according to the Lauren classification and its prognostic significance.
Gastric Cancer
; 23(1): 73-81, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31267360
6.
Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer.
Semin Cancer Biol
; 52(Pt 2): 16-25, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29024776
7.
An auristatin-based antibody-drug conjugate targeting HER3 enhances the radiation response in pancreatic cancer.
Int J Cancer
; 145(7): 1838-1851, 2019 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30882895
8.
Analysis of tumour-infiltrating lymphocytes reveals two new biologically different subgroups of breast ductal carcinoma in situ.
BMC Cancer
; 18(1): 129, 2018 02 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29394917
9.
Neoadjuvant radiotherapy in triple-negative breast cancer: "the past should not steal the present or hide the future".
Rep Pract Oncol Radiother
; 27(1): 180-181, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35402032
10.
Atypical responses to neoadjuvant chemotherapy combined with accelerated partial breast tumor-directed radiotherapy: two cases and considerations for future clinical trials.
Rep Pract Oncol Radiother
; 27(6): 1114-1118, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36632297
11.
Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working group.
Mod Pathol
; 29(10): 1155-64, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27363491
12.
Quantification of HER family receptors in breast cancer.
Breast Cancer Res
; 17: 53, 2015 Apr 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-25887735
13.
SOLTI NeoPARP: a phase II randomized study of two schedules of iniparib plus paclitaxel versus paclitaxel alone as neoadjuvant therapy in patients with triple-negative breast cancer.
Breast Cancer Res Treat
; 154(2): 351-7, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26536871
14.
New-generation technologies for spatial tissue analysis, indispensable tools for deciphering intratumor heterogeneity in the development of antibody-drug conjugates and radio-immunoconjugates for cancer treatment.
Transl Breast Cancer Res
; 4: 28, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38751472
15.
Pathologic Response to Neoadjuvant Sequential Chemoradiation Therapy in Locally Advanced Breast Cancer: Preliminary, Translational Results from the French Neo-APBI-01 Trial.
Cancers (Basel)
; 15(7)2023 Mar 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-37046691
16.
Common cancer-associated PIK3CA activating mutations rarely occur in Langerhans cell histiocytosis.
Blood
; 125(15): 2448-9, 2015 Apr 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-25858893
17.
Nestin as a Prognostic Biomarker in High-grade Epithelial Ovarian Cancer Treated by Neoadjuvant Chemotherapy.
Anticancer Res
; 42(7): 3583-3594, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35790290
18.
WISP2/CCN5 Suppresses Vasculogenic Mimicry through Inhibition of YAP/TAZ Signaling in Breast Cancer Cells.
Cancers (Basel)
; 14(6)2022 Mar 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35326638
19.
Immune microenvironment in patients with mismatch-repair-proficient oligometastatic colorectal cancer exposed to chemotherapy: the randomized MIROX GERCOR cohort study.
Mol Oncol
; 16(11): 2260-2273, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34954864
20.
RNA sequencing reveals the differential expression profiles of RNA in metastatic triple negative breast cancer and identifies SHISA3 as an efficient tumor suppressor gene.
Am J Cancer Res
; 11(9): 4568-4581, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34659906